<?xml version="1.0"?>
<oembed><version>1.0</version><provider_name>Brakke Consulting&#x306E;&#x30A6;&#x30A7;&#x30D6;&#x30B5;&#x30A4;&#x30C8;</provider_name><provider_url>https://brakkeconsulting.com/ja</provider_url><title>News from Brakke Consulting</title><type>rich</type><width>600</width><height>338</height><html>&lt;blockquote class="wp-embedded-content" data-secret="0UhbS9txJn"&gt;&lt;a href="https://brakkeconsulting.com/ja/14070/"&gt;2004&#x5E74;11&#x6708;19&#x65E5;&#x306E;&#x52D5;&#x7269;&#x5065;&#x5EB7;&#x30CB;&#x30E5;&#x30FC;&#x30B9;&#x3068;&#x30CE;&#x30FC;&#x30C8;&lt;/a&gt;&lt;/blockquote&gt;&lt;iframe sandbox="allow-scripts" security="restricted" src="https://brakkeconsulting.com/ja/14070/embed/#?secret=0UhbS9txJn" width="600" height="338" title="&#x201C;Animal Health News &amp; Notes for November 19, 2004&#x201D; &#x2014; Brakke Consulting Website" data-secret="0UhbS9txJn" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"&gt;&lt;/iframe&gt;&lt;script type="text/javascript"&gt;
/* &lt;![CDATA[ */
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&amp;&amp;d.addEventListener&amp;&amp;"undefined"!=typeof URL&amp;&amp;(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&amp;&amp;!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i&lt;o.length;i++)o[i].style.display="none";for(i=0;i&lt;a.length;i++)s=a[i],e.source===s.contentWindow&amp;&amp;(s.removeAttribute("style"),"height"===t.message?(1e3&lt;(r=parseInt(t.value,10))?r=1e3:~~r&lt;200&amp;&amp;(r=200),s.height=r):"link"===t.message&amp;&amp;(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&amp;&amp;n.host===r.host&amp;&amp;l.activeElement===s&amp;&amp;(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r&lt;s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
//# sourceURL=https://brakkeconsulting.com/wp-includes/js/wp-embed.min.js
/* ]]&gt; */
&lt;/script&gt;</html><description>printer friendly version ******************************************************************* &nbsp;Brakke Consulting&rsquo;s &nbsp;Animal Health News &amp; Notes for November 19, 2004 &nbsp;Copyright &copy; Brakke Consulting, Inc. &nbsp;******************************************************************* NOW AVAILABLE FOR PRE-ORDERING: 2004 US FLEA CONTROL &amp; HEARTWORM MARKETS all-new module with transactional data available! see below for details &nbsp; ANNOUNCING ANIMAL HEALTH INDUSTRY BRIEFING NOV. 29 &#x2013; NEW YORK CITY see below for details &nbsp; IN THE NEWS: &nbsp; earnings news: Central Garden &amp; Pet CEVA Heska Gold Kist KMG Chemicals PETCO PETsMART Synbiotics Tyson Foods &nbsp; other news: Aviagen Bayer British United Turkeys of America ImmuCell Lemos Feed &amp; Pet Supply MVP Labs Nagrom Nutrition 21 Virbac &nbsp; ****************************************************************** COMPANY EARNINGS RELEASES &nbsp; &gt;&nbsp; CEVA Sante Animale reported results for the first nine months of 2004. The CEVA group achieved turnover of 165 million euros ($203 million), a 7.2% growth compared to the same period of year 2003. The companion animal ranges increased by 14% in Europe, particularly. The International Zone of the Group remains strongly affected by the avian influenza in South East Asia and exchange rates between euro and US dollar, which restrain exportations from European manufacturing plants. (company information)&nbsp; &nbsp; &gt; Synbiotics announced revenues were $4,333,000 for the third quarter of 2004, an increase of 4% over the prior year period. The increase is primarily due to the re-launch of Synbiotics&rsquo; WitnessView Full Post;</description></oembed>
